Wednesday, 25 May 2022

New sight loss drug made available to thousands on the NHS

New sight loss drug made available to thousands on the NHS A new sight loss drug is to be made available to thousands of people on the NHS a week after it was approved by the medicines regulator.

Faricimab (Vabysmo) is an eye injection made by Roche which works to improve vision – or cut vision loss – in people with wet age-related macular degeneration (wet AMD) or diabetic macular oedema (DMO). The Independent

See also: 

No comments:

Post a Comment